Wound Healing Society Annual Meeting
May 2002. Baltimore, Maryland


Second Messenger Eps8 Is A Gene Therapy Candidate In Wound Healing Yubin Shi*, Jayasri Dasgupta*,Jin-hua Liu*, Mike Slowey*, Gianluca Carlesso*, Susan R. Opalenik*, Michaela Bittner#, , Andreas Goppelt#,Jeffrey M. Davidson*Ý *Department of Pathology, Vanderbilt University, and Ý Research Service, VA Medical Center , Nashville, TN 37212; # Switch-Biotech AG, D-82152 Martinsried, Germany (yubin.shi@mcmail.vanderbilt.ed)

Eps8 (EGFR pathway substrate 8) is a substrate for certain receptor tyrosine kinases and a second messenger in the signal pathway from Ras to Rac. Eps8-null fibroblasts lack PDGF-induced actin reorganization and membrane ruffling, and eps8 enhances the mitogenic response to EGF in fibroblasts. Using a cDNA subtraction strategy, it was found that eps8 mRNA was strongly induced in skin excisional wounds in both normal and diabetic mice. In situ hybridization confirmed local expression. To establish the role of eps8 in wound healing, we transferred murine eps8 cDNA by particle-mediated (gene gun) or adenoviral-mediated methods into various animal wound models. In a rat polyvinyl alcohol sponge implantation model, we injected 107-109 PFU of either Ad-eps8 or Ad-LacZ into sponges 3 days post-implantation. At d7 Ad-eps8 infected sponges displayed much better organization of granulation tissue than controls. The contents of collagen, DNA and protein in Ad-eps8 infected sponges increased 11.2% (p<0.05), 61.2% (p<0.001), and 28.0% (p<0.05). By d10, only protein content was elevated (13.5%, p<0.05). In a rat incisional wound model, gene gun DNA delivery at d0 produced a 52.1% increase of wound strength in normal rats and an 86.8% increase in diabetic rats at d10, although the increase did not reach significance. On d7 after Ad-eps8 injection, the breaking pressure of Ad-eps8 infected wounds in normal rats increased by 23% (p<0.05). In the rabbit ear ulcer model, particle-mediated transduction of eps8 cDNA increased the rate of wound closure by 44% (d5) and 24% (d10) and collagen content 70%. These findings show that eps8 can augment experimental granulation tissue and improve wound strength. Because of its position in the signal transduction pathway, eps8 gene therapy of wounds has the intriguing possibility of sensitizing target cells to multiple growth factors.

Supported by SWITCH Biotech AG


Editor's Note: The content of this abstract is available as it originally appeared in Adobe® Acrobat® PDF file format for download and printing. The Adobe Acrobat Reader software is required to open the PDF file, but is available as a free download.

Click here for PDF version of this file. (12k File)

Click here to download the Free Adobe® Acrobat® Reader.

Copyright © 1995-2002 Surgical Research Laboratory, Inc.
All Rights Reserved.


Website Hosting and Maintenance by Media-Resources.com